Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 341,221 |
|
|||||
| News | - | ||||||
| Day High | 912.74 | Low High |
|||||
| Day Low | 902.50 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 7.16 | 0.80% | 907.32 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 905.66 | 902.50 | 912.74 | 907.32 | 900.16 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,957 | 341,221 | $ 907.88 | $ 309,786,036 | - | 684.805 - 998.325 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:30:21 | 1 | $ 907.32 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 99.59B | 109.76M | - | 13.12B | 3.95B | 36.02 | 25.19 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 892.31 | 920.73 | 890.43 | 896.99 | 470,921 | 15.01 | 1.68% |
| 1 Month | 961.99 | 976.75 | 890.43 | 926.26 | 444,549 | -54.67 | -5.68% |
| 3 Months | 956.00 | 998.325 | 890.43 | 949.68 | 465,747 | -48.68 | -5.09% |
| 6 Months | 810.18 | 998.325 | 769.19 | 895.66 | 515,578 | 97.14 | 11.99% |
| 1 Year | 800.43 | 998.325 | 684.805 | 832.39 | 529,701 | 106.89 | 13.35% |
| 3 Years | 487.62 | 998.325 | 478.40 | 697.94 | 650,056 | 419.70 | 86.07% |
| 5 Years | 335.51 | 998.325 | 271.37 | 581.47 | 772,131 | 571.81 | 170.43% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
